問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
National Taiwan University Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2015-06-08 - 2019-09-16
Condition/Disease
ALK-Positive Non Small Cell Lung Cancer metastatic to the brain and/or to leptomeninges
Test Drug
LDK378
Participate Sites3Sites
Terminated3Sites
2014-05-01 - 2019-03-31
Acute Heart Failure Patients
REASANZ
Participate Sites10Sites
Terminated10Sites
2013-05-01 - 2014-12-30
Participate Sites9Sites
Terminated9Sites
2012-06-01 - 2014-06-30
2013-01-01 - 2016-12-31
2009-03-01 - 2017-03-01
Participate Sites6Sites
Terminated6Sites
2008-11-01 - 2010-12-31
Participate Sites4Sites
Terminated4Sites
2008-07-01 - 2012-02-28
2010-05-01 - 2013-12-31
2010-06-01 - 2012-12-31
全部
